Rocuronium + Sugammadex vs. Succinylcholine + Cisatracurium + Neostigmine/Atropine in Obese Participants (MK-8616-104)
Status:
Withdrawn
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to compare the preference between two strategies of
neuromuscular blocking (NMB) / reversal in adult obese patients undergoing laparoscopic
abdominal surgery: Rocuronium + Sugammadex versus Succinylcholine + Cisatracurium +
Neostigmine/Atropine. This will be done evaluating the average verbal numerical scale (VNS)
scores obtained from surgeons blinded to the drugs administered. The primary hypothesis is
that the strategy "Rocuronium + Sugammadex" provides a better surgical visual field in obese
participants undergoing laparoscopic abdominal surgery than the strategy "Succinylcholine +
Cisatracurium + Neostigmine/Atropine" as measured by VNS scores.